salvage therapy

DRUG6 trials

Sponsors

The HIV Netherlands Australia Thailand Research Collaboration, H. Lee Moffitt Cancer Center and Research Institute, Tanta University, Harbin Hematology and Oncology Institute, Melanoma Institute Australia

Conditions

B-precursor Acute Lymphoblastic LeukemiaHIV InfectionsHepatitis CMelanoma Stage IvPeripheral T Cell LymphomaProstate Cancer

Phase 2

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

TerminatedNCT01531205

H. Lee Moffitt Cancer Center and Research InstituteProstate Cancer

Start: 2012-05-31End: 2013-10-31Updated: 2014-11-05

Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)

RecruitingNCT03340129

Melanoma Institute AustraliaMelanoma Stage Iv

Start: 2019-08-14End: 2029-08-01Target: 218Updated: 2026-02-02

Phase 4

Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection

CompletedNCT02992457

Tanta UniversityHepatitis C

Start: 2015-01-31End: 2019-12-31Updated: 2023-08-25

Unknown Phase

Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs

CompletedNCT00477308

The HIV Netherlands Australia Thailand Research CollaborationHIV Infections

Start: 2006-01-31End: 2009-04-30Updated: 2020-07-17

Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL

CompletedNCT03123887

Harbin Hematology and Oncology InstituteB-precursor Acute Lymphoblastic Leukemia

Start: 2015-07-10End: 2016-10-10Updated: 2017-04-21

T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR

RecruitingNCT07470996

Shanghai General Hospital, Shanghai Jiao Tong University School of MedicinePeripheral T Cell Lymphoma

Start: 2025-10-01End: 2029-09-30Target: 58Updated: 2026-03-13

Related Papers

Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial

Clinical and Translational Radiation Oncology2023-02-152 citations

Five-year overall survival from the anti-PD1 brain collaboration (ABC Study): Randomized phase 2 study of nivolumab (nivo) or nivo+ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets).

Journal of Clinical Oncology2021-05-2098 citations

High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir therapy: a real-life experience.

2020-04-305 citations

A phase II, open label, randomized controlled trial of nivolumab plus ipilimumab with stereotactic radiotherapy versus ipilimumab plus nivolumab alone in patients with melanoma brain metastases (ABC-X Trial).

Journal of Clinical Oncology2019-05-2024 citations

Efficacy and safety of sofosbuvir&ndash;ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection

Infection and Drug Resistance2018-02-2840 citations